7NAM image
Deposition Date 2021-06-21
Release Date 2022-06-29
Last Version Date 2024-10-23
Entry Detail
PDB ID:
7NAM
Title:
LRP6_E1 in complex with Lr-EET-3.5
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.60 Å
R-Value Free:
0.19
R-Value Work:
0.17
R-Value Observed:
0.17
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Low-density lipoprotein receptor-related protein 6
Gene (Uniprot):LRP6
Chain IDs:A
Chain Length:317
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Trypsin inhibitor 2
Chain IDs:B
Chain Length:32
Number of Molecules:1
Biological Source:synthetic construct
Ligand Molecules
Primary Citation
Directed evolution identifies high-affinity cystine-knot peptide agonists and antagonists of Wnt/ beta-catenin signaling.
Proc.Natl.Acad.Sci.USA 119 e2207327119 e2207327119 (2022)
PMID: 36343233 DOI: 10.1073/pnas.2207327119

Abstact

Developing peptide-based tools to fine-tune growth signaling pathways, in particular molecules with exquisite selectivity and high affinities, opens up opportunities for cellular reprogramming in tissue regeneration. Here, we present a library based on cystine-knot peptides (CKPs) that incorporate multiple loops for randomization and selection via directed evolution. Resulting binders could be assembled into multimeric structures to fine-tune cellular signaling. An example is presented for the Wnt pathway, which plays a key role in the homeostasis and regeneration of tissues such as lung, skin, and intestine. We discovered picomolar affinity CKP agonists of the human LPR6 receptor by exploring the limits of the topological manipulation of LRP6 dimerization. Structural analyses revealed that the agonists bind at the first β-propeller domain of LRP6, mimicking the natural Wnt inhibitors DKK1 and SOST. However, the CKP agonists exhibit a different mode of action as they amplify the signaling of natural Wnt ligands but do not activate the pathway by themselves. In an alveolosphere organoid model, the CKP agonists induced alveolar stem cell activity. They also stimulated growth in primary human intestinal organoids. The approach described here advances the important frontier of next-generation agonist design and could be applied to other signaling pathways to discover tunable agonist ligands.

Legend

Protein

Chemical

Disease

Primary Citation of related structures